Literature DB >> 29224419

Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases.

Huiya Huang1, Gabriela Gheorghe1,2, Paula E North1,2, Mariko Suchi1,2.   

Abstract

ALK-positive histiocytosis is a recently described rare histiocytic proliferative disorder of early infancy. When infants present with anemia, thrombocytopenia, and hepatosplenomegaly, this entity should be included in the differential diagnosis along with hemophagocytic lymphohistiocytosis, metabolic/storage diseases, hematopoietic malignancies, and autoimmune thrombocytopenia. We report 2 new cases of ALK-positive histiocytosis, one with kidney involvement and the other with extensive bone marrow involvement in addition to an overt liver disease. Renal involvement by ALK-positive histiocytosis has not been reported. The infiltrating histiocytes in this case showed Rosai-Dorfman disease-like morphology including emperipolesis. The histiocytes in the second case with extensive bone marrow involvement had foamy cytoplasm initially suggesting storage disease. Our 2 cases highlight previously unrecognized diversity of ALK-positive histiocytosis in clinical manifestation, organ involvement, and cytomorphologic features and further elucidate the diagnostic challenges of this rare entity.

Entities:  

Keywords:  ALK; Rosai–Dorfman disease; hepatomegaly; histiocytosis; infant; kidney; thrombocytopenia

Mesh:

Substances:

Year:  2017        PMID: 29224419     DOI: 10.1177/1093526617740784

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  8 in total

1.  ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.

Authors:  Calixto-Hope G Lucas; Ahmed Gilani; David A Solomon; Xiayuan Liang; Ossama M Maher; Gabriel Chamyan; Bette K Kleinschmidt-Demasters; Arie Perry
Journal:  Acta Neuropathol       Date:  2019-05-22       Impact factor: 17.088

2.  Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by Alectinib.

Authors:  Yanchu Li; Changle Shi; Yu Wu; Mingmin He; Xueming Xia; Jie Liu; Yu Jiang
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 3.  Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.

Authors:  Qiang He; Wenjie Zhang; Qiang Li
Journal:  BMC Pediatr       Date:  2022-05-25       Impact factor: 2.567

4.  ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.

Authors:  Charlotte Syrykh; Loïc Ysebaert; Sarah Péricart; Solène M Evrard; Fabienne Meggetto; Salim Kanoun; Pierre Brousset; Camille Laurent
Journal:  Virchows Arch       Date:  2020-10-03       Impact factor: 4.064

5.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

Review 6.  Case Report: ALK-Positive Histiocytosis With KIF5B-ALK Fusion in Cerebrum-Disseminated Lesions in a Child.

Authors:  Yi Guo; Hai-Bo Qu; Gang Ning; Feng-Lin Jia; Hong Liu; Xin-Mao Ma; Yi Liao
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

7.  Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion.

Authors:  Yuzuna Aoki; Masayuki Maeda; Seiya Kishi; Ryota Kogue; Fumine Tanaka; Maki Umino; Mami Takeoka; Ryo Hanaki; Junya Hirayama; Hiroto Yuasa; Hiroshi Imai; Masahiro Hirayama; Hajime Sakuma
Journal:  Radiol Case Rep       Date:  2022-08-10

8.  A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report.

Authors:  Arisa Kurita; Masayuki Yoshida; Takeshi Murata; Akihiko Yoshida; Nachiko Uchiyama; Shin Takayama
Journal:  Int J Surg Case Rep       Date:  2022-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.